2 Stocks That May Benefit from Data Center Build-out
TG and MCEM may benefit from data center construction.
TG - Tredegar Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
Stock News
Tredegar Appoints Cindy Yao as Vice President, Chief Financial Officer and Treasurer
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Appoints Cindy Yao as Chief Financial Officer.
Arrowhead Pharmaceuticals Announces Interim Topline Clinical Data for the First Dual-Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia
[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced interim topline data from a Phase 1/2a clinical trial of ARO-DIMER-PA, the company's
Tredegar Announces Departure of Kevin Donnelly, Executive Vice President, General Counsel and Corporate Secretary
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Corporation (NYSE:TG) today announced that Kevin C. Donnelly, Executive Vice President, General Counsel and Corporate Secretary, will resign from the Company, effective October 1, 2026.“Kevin has been an exceptional legal advisor and a trusted member of Tredegar's leadership team,” said Dr. Arijit (Bapi) DasGupta, President and Chief Executive Officer of Tredegar. “During his 16 years with the Company, including more than five and a half years as an execu.
Tredegar Provides Update on One Tredegar Transformation
RICHMOND, Va.--(BUSINESS WIRE)--One Tredegar Transformation Update.
BlackRock Inc. Purchases New Position in Tredegar Corporation $TG
BlackRock Inc. purchased a new stake in Tredegar Corporation (NYSE: TG) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 2,405,863 shares of the basic materials company's stock, valued at approximately $19,151,000. BlackRock Inc. owned 6.87% of Tredegar at the end of
Connor Clark & Lunn Investment Management Ltd. Buys New Position in Tredegar Corporation $TG
Connor Clark and Lunn Investment Management Ltd. bought a new stake in Tredegar Corporation (NYSE: TG) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 98,400 shares of the basic materials company's stock, valued at approximately $783,000. Connor Clark
Arrowhead Pharmaceuticals Presents Phase 3 SHASTA-3 and SHASTA-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented results from the pivotal Phase 3 SHASTA-3 and SHASTA-4 studies of plozasiran in adults with sever
Tredegar Announces Election of Ana Dutra to Board of Directors
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES ELECTION OF ANA DUTRA TO BOARD OF DIRECTORS.
Tredegar Q2 Earnings Rise Y/Y on Aluminum Extrusions Gains
TG's Q2 earnings per share and sales improve year over year as Aluminum Extrusions benefit from favorable metal dynamics and rising TSLOTS demand, offsetting softer volumes and weaker High Performance Films EBITDA.
Tredegar (NYSE:TG) Share Price Crosses Above 200 Day Moving Average – Here’s Why
Tredegar Corporation (NYSE: TG - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $8.29 and traded as high as $8.39. Tredegar shares last traded at $7.8570, with a volume of 302,646 shares trading hands. Analyst Ratings Changes Separately, Weiss Ratings
Tredegar Reports Second Quarter 2026 Results
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR REPORTS SECOND QUARTER 2026 RESULTS.
Tredegar Plans to Release Second Quarter 2026 Financial Results on August 7, 2026
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR PLANS TO RELEASE SECOND QUARTER 2026 FINANCIAL RESULTS ON AUGUST 7, 2026.
Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026
RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES THE RETIREMENT OF FRASIER W. BRICKHOUSE II, CHIEF FINANCIAL OFFICER, TREASURER AND VICE PRESIDENT, EFFECTIVE SEPTEMBER 1, 2026.
Arrowhead Pharmaceuticals Reports Topline Results from Phase 3 SHASTA-3 and SHASTA-4 Studies of Plozasiran in Patients with Severe Hypertriglyceridemia
[url="]Arrowhead Pharmaceuticals, Inc.[/url] (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of pl
TRYNGOLZA® (olezarsen) approved by the FDA as the first and only treatment to reduce triglycerides and the risk of acute pancreatitis in patients with severe hypertriglyceridemia (sHTG)
[url="]Ionis Pharmaceuticals, Inc.[/url] (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZAÂ (olezarsen) a
Trifecta Gold Increases Private Placement
NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES AND NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES VANCOUVER, BC / ACCESS Newswire / June 17, 2026 / Trifecta Gold Ltd. (TSXV:TG)(OTCQB:TRRFF) ("Trifecta" or the "Company") announces that further to its news release dated June 15, 2026, the Company has increased its previously announced Private Placement of Flow-through shares to consist of the sale of up to 5,750,000 Flow-through shares at a price of $0.20 per Flow-through share.
Grafton Group Sets 2030 Growth Targets as Cash Flow and Acquisitions Take Center Stage
Grafton Group LON: GFTU outlined a five-year growth plan at its Capital Markets Event, with management emphasizing the company's European distribution platform, cash generation and acquisition strategy as key drivers of shareholder value through 2030.
Tredegar Announces Bonnell Aluminum Leadership Changes
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Bonnell Leadership Changes.
Tredegar Announces Director Transitions
RICHMOND, Va.--(BUSINESS WIRE)--Tredegar Announces Director Transitions.